(Q66392102)
Statements
A Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 (Galcanezumab) in Japanese Patients With Episodic Migraine (English)
0 references
9 November 2016
0 references
18 January 2019
0 references
451
0 references
18 year
0 references
65 year
0 references